JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kairaluoma, M. I.
Right arrow Articles by Larmi, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kairaluoma, M. I.
Right arrow Articles by Larmi, T. K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 73, 783-786, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Celestin tube palliation of unresectable esophageal carcinoma

MI Kairaluoma, K Jokinen, P Karkola and TK Larmi

Celestin tube intubation was performed in 108 patients with unresectable carcinoma of the esophagus and cardia, in 83 per cent as the initial operation and in 17 per cent after exploration. The hospital mortality rate was 16 per cent, including a 7.4 per cent mortality rate from technical causes. The most frequent causes of death were perforations of the esophagus and cardia and aspiration pneumonia. Nonfatal complications occurred in 13 per cent of surviving patients, obstruction and dislodgment of the tube being the most common. All patients were able to swallow at discharge, and 91 per cent of them could take food by mouth until the time of death. In 9 per cent, additional palliation, usually esophagoscopy or gastrostomy, was required. Ninety-one patients survived one to 21 months (average 5.8 months). The 6 month survival rate was 44 per cent and the one-year survival 9 per cent.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P.-y. Wang, C.-y. Chen, and C.-l. Chen
A Check-Valve Device for Prevention of Regurgitation After Endoesophageal Intubation
Ann. Thorac. Surg., November 1, 1986; 42(5): 565 - 567.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
P.-Y. Wang, T.-J. Yeh, C.-L. Chen, and C.-Y. Chen
A Spiral-Grooved Endoesophageal Tube for Management of Malignant Esophageal Obstruction
Ann. Thorac. Surg., June 1, 1985; 39(6): 503 - 507.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. A. Keagy, G. F. Murray, P. J. K. Starek, J. W. Battaglini, M. E. Lores, and B. R. Wilcox
Esophagogastrectomy as Palliative Treatment for Esophageal Carcinoma: Results Obtained in the Setting of a Thoracic Surgery Residency Program
Ann. Thorac. Surg., December 1, 1984; 38(6): 611 - 616.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Hankins, F. N. Cole, S. Attar, J. R. Satterfield, and J. S. McLaughlin
Palliation of Esophageal Carcinoma with Intraluminal Tubes: Experience with 30 Patients
Ann. Thorac. Surg., September 1, 1979; 28(3): 224 - 229.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The American Association for Thoracic Surgery.